5-Bromo-2-((tetrahydrofuran-3-yl)oxy)pyridine

Catalog No.: 
ACIQKO619
CAS No.: 
494771-98-1
Molecular Formula: 
C9H10BrNO2
Molecular Weight: 
244.09
5-Bromo-2-((tetrahydrofuran-3-yl)oxy)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$360.00InquiryInquiry
1g98%$1134.00InquiryInquiry
5g98%$2269.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-((tetrahydrofuran-3-yl)oxy)pyridine
IUPAC Name5-bromo-2-((tetrahydrofuran-3-yl)oxy)pyridine
Molecular FormulaC9H10BrNO2
Molecular Weight244.09
SMILESBrC1=CN=C(OC2COCC2)C=C1
InChI KeyMUUIXVLMQRHUBN-UHFFFAOYSA-N
Synonym5-bromo-2-[(tetrahydro-3-furanyl)oxy]Pyridine;5-bromo-2-((tetrahydrofuran-3-yl)oxy)pyridine;3-Bromo-6-(tetrahydrofuran-3-yloxy)pyridine;Pyridine, 5-bromo-2-[(tetrahydro-3-furanyl)oxy]-
CAS No.494771-98-1

Synthetic Route by SureRoute

1. ACIQKO619 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIWBF532 route compound structure diagram
    ACIWBF532766-11-0In Stock
  2. Plus
  3. ACHJGS164 route compound structure diagram
    ACHJGS164453-20-3In Stock
  4. Then
  5. ACIQKO619 route product structure diagram
    ACIQKO619494771-98-1
Inquiry

2. ACIQKO619 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCKWO017 route compound structure diagram
    ACCKWO017624-28-2In Stock
  2. Plus
  3. ACHJGS164 route compound structure diagram
    ACHJGS164453-20-3In Stock
  4. Then
  5. ACIQKO619 route product structure diagram
    ACIQKO619494771-98-1
Inquiry

3. ACIQKO619 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHJGS164 route compound structure diagram
    ACHJGS164453-20-3In Stock
  2. Plus
  3. ACPUSF613 route compound structure diagram
    ACPUSF61349843-23-4In Stock
  4. Then
  5. ACIQKO619 route product structure diagram
    ACIQKO619494771-98-1
Inquiry

Comments (0)